Mihai Harza

Mihai Harza

Auto-generated profile, based on publicly available information

Mihai Harza

Center of Urological Surgery, Dialysis and Renal Transplantation, Fundeni Clinical Institute

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Transplantation Proceedings
Verified
Journal Article
Closed access
CBC. Baston
C. Baston
MHM. Harza
M. Harza
APA. Preda
A. Preda
IGI. Gener
I. Gener
IMI. Manea
I. Manea
ISI. Sinescu
I. Sinescu

1 January 2013
Verified
Journal Article
Closed access
MHM Hârza
M Hârza
GIG Ismail
G Ismail
GMG Mitroi
G Mitroi
MGMihaela Gherghiceanu
Mihaela Gherghiceanu
APA Preda
A Preda
ISIoanel C. Sinescu
Ioanel C. Sinescu

19 May 2020 in Medicina
Verified
Journal Article
Open access
PDF file
GIGener Ismail
Gener Ismail
BOBogdan Obrisca
Bogdan Obrisca
RJRoxana Jurubiță
Roxana Jurubiță
AAAndreea Andronesi
Andreea Andronesi
SBSorohan Bogdan
Sorohan Bogdan
MHMihai Hârza
Mihai Hârza
Background and objectives. Venous thromboembolic events (VTEs) are among the most important complications of nephrotic syndrome (NS). We conducted a study that aimed to determine the prevalence of inherited risk factors for VTE in NS and to identify which factors are independent predictors of VTE. Materials and Methods. Thirty-six consecutive patients with primary NS that underwent percutaneous kidney biopsy between January 2017 and December 2017 were enrolled in this retrospective, observational study. VTEs were the primary outcome. Baseline demographic and biochemical data were collected from medical records, and genetic testing was done for polymorphisms of Factor V, PAI, MTHFR, and prothrombin genes. Results. The incidence of VTE was 28%, and the median time to event was 3 months (IQR: 2–9). The prevalence of inherited risk factors was 14% for Factor V Leiden mutation, 5.6% for prothrombin G20210A, 44.5% for PAI, and 27.8% for each of the two polymorphisms of the MTHFR gene. On multivariate analysis, the presence of at least two mutations was independently associated with the risk of VTE (HR, 8.92; 95% confidence interval, CI: 1.001 to 79.58, p = 0,05). Conclusions. These findings suggest that genetic testing for inherited thrombophilia in NS could play an important role in detecting high-risk patients that warrant prophylactic anticoagulation.

27 April 2020 in Medicina
Verified
Journal Article
Open access
PDF file
SBSorohan Bogdan
Sorohan Bogdan
AAAndreea Andronesi
Andreea Andronesi
GIGener Ismail
Gener Ismail
RJRoxana Jurubita
Roxana Jurubita
BOBogdan Obrisca
Bogdan Obrisca
MHMihai Harza
Mihai Harza
Background and Objectives: Pregnant women with chronic kidney disease (CKD) are at high risk of adverse maternal and fetal outcomes. Preeclampsia (PE) superimposed on CKD is estimated to occur in 21%–79% of pregnancies. Both conditions share common features such as proteinuria and hypertension, making differential diagnosis difficult. Objective: The aim of this study was to evaluate the incidence and the clinical-biological predictors of preeclampsia in pregnant women with CKD. Material and Methods: We retrospectively analyzed 34 pregnant women with pre-existing CKD admitted to our department between 2008 and 2017. Results: Among the 34 patients, 19 (55.8%) developed PE and the mean time of occurrence was 31.26 ± 2.68 weeks of gestation. The median value of 24-h proteinuria at referral was 0.87 g/day (interquartile range 0.42–1.50) and 47.1% of patients had proteinuria of ≥1 g/day. Patients with PE tended to be more hypertensive, with a more decreased renal function at referral and had significantly higher proteinuria (1.30 vs. 0.63 g/day, p = 0.02). Cox multivariate analysis revealed that proteinuria ≥1 g/day at referral and pre-existing hypertension were independently associated with PE (adjusted hazard ratio = 4.10, 95% confidence interval: 1.52–11.02, p = 0.005, adjusted hazard ratio = 2.62, 95% confidence interval: 1.01–6.77, p = 0.04, respectively). The cumulative risk of PE was significantly higher in pregnant women with proteinuria ≥1 g/day at referral (log-rank, p = 0.003). Proteinuria ≥ 1 g/day at referral and pre-exiting hypertension predicted PE development with accuracies of 73.5% and 64.7%, respectively. Conclusions: Pregnant patients with pre-existing CKD are at high risk of developing preeclampsia, while proteinuria ≥ 1 g/day at referral and pre-existing hypertension were independent predictors of superimposed preeclampsia.

30 September 2010 in European Urology Supplements
Verified
Journal Article
Closed access
ISI. Sinescu
I. Sinescu
MHM. Harza
M. Harza
BSB. Serbanescu
B. Serbanescu
BSB. Stefan
B. Stefan
CBC. Baston
C. Baston
Surcel CristianSurcel Cristian
Surcel Cristian

30 September 2011 in Urology
Verified
Journal Article
Closed access
CCC. Chibelean
C. Chibelean
Surcel CristianSurcel Cristian
Surcel Cristian
CGConstantin Gingu
Constantin Gingu
CMC. Moldovan
C. Moldovan
SVS. Voinea
S. Voinea
SPS. Patrascoiu
S. Patrascoiu